Author

Chris-Anne McKenzie

University of Edinburgh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Organism:Drosophila· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1

Frequent Co-Authors

Colin SmithiD· 3 shared Abigail G. Herrmann· 2 shared Christopher M. HenstridgeiD· 2 shared Jamie L. RoseiD· 2 shared Jane TullochiD· 2 shared Makis TziorasiD· 2 shared Rosemary J. JacksoniD· 2 shared Tara L. Spires‐JonesiD· 2 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Colin SmithORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The remarkable complexity of the brain microbiome in health and disease

Xinyue Hu, Chris-Anne McKenzie, Colin Smith, Juergen Haas, Richard Lathe

This paper identifies diverse brain microbes in health and disease, finding over-represented pathogens in Alzheimer's brain samples.

bioRxiv · Feb 6, 2023 · PreprintNeuroscience

Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype

Raphael Hesse, Maica Llavero Hurtado, Rosemary J. Jackson, Samantha L. Eaton, Abigail G. Herrmann, Martí Colom‐Cadena, Makis Tzioras, Declan King, Jamie L. Rose, Jane Tulloch, Chris-Anne McKenzie, Colin Smith, Christopher M. Henstridge, Douglas J. Lamont, Thomas M. Wishart, Tara L. Spires‐Jones

The paper identifies over 5,500 synaptic proteins in Alzheimer’s disease and controls, revealing APOE4-associated changes in synaptic and mitochondrial function and neuroimmune signaling.

Acta Neuropathologica Communications · Dec 1, 2019Peer-reviewedNeuroscience

Reducing tau ameliorates behavioural and transcriptional deficits in a novel model of Alzheimer’s disease

Eleanor K. Pickett, Abigail G. Herrmann, Jamie McQueen, Kimberly M. Abt, Owen Dando, Jane Tulloch, Pooja Jain, Sophie Louise Dunnett, Sadaf Sohrabi, Maria P. Fjeldstad, Will Calkin, Leo Murison, Rosemary J. Jackson, Makis Tzioras, Anna J. Stevenson, , Tara L. Spires‐Jones

This study shows that reducing tau improves behavioural and transcriptional issues in a mouse model of Alzheimer’s disease, suggesting synaptic tau reduction could be a therapeutic strategy.

bioRxiv · Aug 16, 2018 · PreprintNeuroscience